Literature DB >> 25236831

Outcomes of intensive care management of traumatic brain injury in a resource-challenged tertiary health centre.

A S Yusuf1, Z A Suleiman, I Olaoye, B O Bolaji, N A Adeleke, T O Odebode.   

Abstract

BACKGROUND: Improved surgical care and protocol-driven intensive care interventions for head injured patients have contributed to the overall reduction in mortality in developed countries. The aim of this study is to highlight the clinical outcomes of patients with severe traumatic brain injury managed in the multispecialty ICU of our institution. STUDY
DESIGN: The medical records of all patients with severe TBI managed in our 3-bedded non-dedicated ICU over a 24-month period were reviewed. Data on demographic characteristics, mechanism of injury, neuroimaging and interventions were obtained and the primary outcome measure was the mortality.
RESULTS: Fifty one patients, age ranged from 2-75 years and median age of 30 years were studied. The male sex was more involved (M;F of 12;1) and motorcycle crashes caused the majority of the injury (19,{37%}). None of the patients received pre-hospital care and about half (25 {49 %}) presented six hours post trauma. Cranial CT scan showed intracranial haemorrhage in 7 of the 21 patients stabled for neuroimaging. Overall mortality was 70%, with highest mortality recorded in those who did not have post injury brain CT scan (58% vs 82%, p = 0.066).
CONCLUSION: Mortality from severe TBI is very high in our environment where routine pre-hospital care and prompt transfer to neurosurgical centres are not practiced. Lack of facilities for monitoring intracranial pressure and arterial blood gases in our ICU also contributed to the high mortality.

Entities:  

Mesh:

Year:  2014        PMID: 25236831

Source DB:  PubMed          Journal:  West Afr J Med        ISSN: 0189-160X


  1 in total

1.  The epidemiology and outcome of critical illness in Mongolia: A multicenter, prospective, observational cohort study.

Authors:  Naranpurev Mendsaikhan; Tsolmon Begzjav; Ganbold Lundeg; Martin W Dünser
Journal:  Int J Crit Illn Inj Sci       Date:  2016 Jul-Sep
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.